Daratumumab (MM)
Ixazomib
Elotuzumab
Carfilzomib
NCCN-Funded Clinical Trials: Find a Clinical Trial
CancerCare
NCCN Guidelines for Patients: Multiple Myeloma
National Cancer Institute (NCI) - Supported Cancer Clinical Trials